Life Science REIT plc Share Price

Equities

LABS

GB00BP5X4Q29

Residential REITs

Market Closed - London S.E. 16:35:29 26/04/2024 BST 5-day change 1st Jan Change
39.1 GBX +0.51% Intraday chart for Life Science REIT plc +2.89% -38.13%

Financials

Sales 2024 * 19.3M 24.21M 1.93B Sales 2025 * 23.87M 29.93M 2.39B Capitalization 137M 172M 13.68B
Net income 2024 * 10M 12.54M 1B Net income 2025 * 14M 17.56M 1.4B EV / Sales 2024 * 13.8 x
Net Debt 2024 * 130M 164M 13.04B Net Debt 2025 * 147M 184M 14.66B EV / Sales 2025 * 11.9 x
P/E ratio 2024 *
12.6 x
P/E ratio 2025 *
9.54 x
Employees -
Yield 2024 *
7.03%
Yield 2025 *
7.57%
Free-Float 93.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.51%
1 week+2.89%
Current month-0.51%
1 month-0.51%
3 months-34.83%
6 months-36.94%
Current year-38.13%
More quotes
1 week
38.00
Extreme 38
39.90
1 month
37.00
Extreme 37
42.00
Current year
37.00
Extreme 37
65.00
1 year
37.00
Extreme 37
77.40
3 years
37.00
Extreme 37
106.00
5 years
37.00
Extreme 37
106.00
10 years
37.00
Extreme 37
106.00
More quotes
Members of the board TitleAgeSince
Director/Board Member 59 02/05/22
Director/Board Member 62 -
Director/Board Member 63 13/10/21
More insiders
Date Price Change Volume
26/04/24 39.1 +0.51% 4,418,664
25/04/24 38.9 +0.78% 255,554
24/04/24 38.6 -1.53% 564,054
23/04/24 39.2 +1.29% 672,084
22/04/24 38.7 +1.84% 284,287

Delayed Quote London S.E., April 26, 2024 at 04:35 pm

More quotes
Life Science REIT plc is a United Kingdom-based closed-ended real estate investment trust. The Company seeks to invests in a diversified portfolio of properties across the United Kingdom, which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. It acquires or develops properties, such as wet and dry laboratories, offices, incubators and co-working space, manufacturing and testing facilities and data centers. It retains flexibility to acquire individual buildings, a group of buildings across a single science park or the entirety of a science park. This may include purchasing or developing buildings that are leased or intended to be leased to tenants providing ancillary services to employees of companies operating in or providing a benefit to, the life science sector. Its investment adviser is Ironstone Asset Management Limited.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.391 GBP
Average target price
0.6067 GBP
Spread / Average Target
+55.16%
Consensus

Annual profits - Rate of surprise